These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. Spontaneous reporting of adverse reactions associated with the COVID-19 vaccine in health care professionals: A descriptive observational study conducted in a Portuguese hospital. Teófilo VSG; Pinho PRA; Cordeiro GJ; Saldanha NAF; Matos PMM; Ribeiro RAM; Moreira SM; Miller MSF; Dias ARM; Couto MFR; Norton PMPNS Porto Biomed J; 2023; 8(3):e219. PubMed ID: 37383526 [TBL] [Abstract][Full Text] [Related]
103. COVID-19 Vaccines Are Safely Tolerated in Adolescents with Cutaneous Mastocytosis. Yuksel Bulut H; Ulusoy Severcan E; Ertugrul A Int Arch Allergy Immunol; 2023; 184(8):776-782. PubMed ID: 37071972 [TBL] [Abstract][Full Text] [Related]
104. [Skin reactions to the Pfizer-BioNTech vaccine for COVID-19. An Ecuadorian experience]. Chérrez-Ojeda I; Robles-Velasco K; Osorio MF; Mejía-Leiva D; Chérrez A; Chérrez S; Bernstein JA; Sarfraz Z; Félix M Rev Alerg Mex; 2022 Jun; 69(1):61-64. PubMed ID: 36927752 [TBL] [Abstract][Full Text] [Related]
105. What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later. Copaescu AM; Rosa Duque JS; Phillips EJ Ann Allergy Asthma Immunol; 2022 Jul; 129(1):40-51. PubMed ID: 35390476 [TBL] [Abstract][Full Text] [Related]
106. The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines. Rosen B; Davidovitch N; Chodick G; Israeli A Isr J Health Policy Res; 2022 Nov; 11(1):39. PubMed ID: 36419188 [TBL] [Abstract][Full Text] [Related]
108. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Sampath V; Rabinowitz G; Shah M; Jain S; Diamant Z; Jesenak M; Rabin R; Vieths S; Agache I; Akdis M; Barber D; Breiteneder H; Chinthrajah S; Chivato T; Collins W; Eiwegger T; Fast K; Fokkens W; O'Hehir RE; Ollert M; O'Mahony L; Palomares O; Pfaar O; Riggioni C; Shamji MH; Sokolowska M; Jose Torres M; Traidl-Hoffmann C; van Zelm M; Wang Y; Zhang L; Akdis CA; Nadeau KC Allergy; 2021 Jun; 76(6):1640-1660. PubMed ID: 33811364 [TBL] [Abstract][Full Text] [Related]
109. Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose. Regula P; Rosenstreich D; Jerschow E; Ramesh M; Ferastraoaru D; Oh J; Aivazi DS; Aivazi JM; Hudes G J Allergy Clin Immunol Glob; 2022 Aug; 1(3):175-177. PubMed ID: 36164368 [TBL] [Abstract][Full Text] [Related]
110. Signals of hope: gauging the impact of a rapid national vaccination campaign. Shilo S; Rossman H; Segal E Nat Rev Immunol; 2021 Apr; 21(4):198-199. PubMed ID: 33712744 [TBL] [Abstract][Full Text] [Related]
111. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI. Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162 [TBL] [Abstract][Full Text] [Related]
112. Use of adrenaline to manage suspected anaphylaxis following COVID-19 vaccination: An Australian retrospective cohort study. Deng L; Tapper K; Thosar D; Goeman E; Baker L; Adelstein S; Boyle M; Brown DA; Evans L; Katelaris C; Lee F; Li J; Swaminathan S; Taylor MS; Wong M; Wood N Vaccine; 2023 Sep; 41(41):5987-5993. PubMed ID: 37633752 [TBL] [Abstract][Full Text] [Related]
113. Anaphylaxis After the Covid-19 Vaccine in a Patient With Cholinergic Urticaria. Park HJ; Montgomery JR; Boggs NA Mil Med; 2022 Dec; 187(9):e1556-e1558. PubMed ID: 33851711 [TBL] [Abstract][Full Text] [Related]
114. A practical guide to address reactions to vaccines in children. Arcolaci A; Scarmozzino R; Zanoni G Pediatr Allergy Immunol; 2023 Jun; 34(6):e13967. PubMed ID: 37366202 [TBL] [Abstract][Full Text] [Related]
115. Infrastructural capital in the Israeli vaccination campaign against COVID-19. Tubi O Soc Sci Med; 2022 Jun; 303():115022. PubMed ID: 35569233 [TBL] [Abstract][Full Text] [Related]
116. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee. Turner PJ; Ansotegui IJ; Campbell DE; Cardona V; Ebisawa M; El-Gamal Y; Fineman S; Geller M; Gonzalez-Estrada A; Greenberger PA; Leung ASY; Levin ME; Muraro A; Sánchez Borges M; Senna G; Tanno LK; Yu-Hor Thong B; Worm M; World Allergy Organ J; 2021 Feb; 14(2):100517. PubMed ID: 33558825 [TBL] [Abstract][Full Text] [Related]
117. Self-Reported Allergic Adverse Events Following Inactivated SARS-CoV-2 Vaccine (TURKOVAC™) among General and High-Risk Population. Kara A; Coskun A; Temel F; Özelci P; Topal S; Ates İ Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851314 [TBL] [Abstract][Full Text] [Related]
118. Anaphylactic reactions after COVID-19 vaccination in Germany. Barth I; Weißer K; Gaston-Tischberger D; Mahler V; Keller-Stanislawski B Allergol Select; 2023; 7():90-100. PubMed ID: 37056447 [TBL] [Abstract][Full Text] [Related]
119. Patients with suspected allergic reactions to COVID-19 vaccines can be safely revaccinated after diagnostic work-up. Rasmussen TH; Mortz CG; Georgsen TK; Rasmussen HM; Kjaer HF; Bindslev-Jensen C Clin Transl Allergy; 2021 Jul; 11(5):e12044. PubMed ID: 34331522 [TBL] [Abstract][Full Text] [Related]
120. Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital. Paoletti G; Racca F; Piona A; Melone G; Merigo M; Puggioni F; Ferri S; Azzolini E; Lagioia M; Lamacchia D; Cataldo G; Cecconi M; Canonica GW; Heffler E World Allergy Organ J; 2021 May; 14(5):100541. PubMed ID: 33850601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]